Goldman Sachs’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $997K | Sell |
791,616
-31,224
| -4% | -$39.3K | ﹤0.01% | 3846 |
|
|
2025
Q1 | $751K | Sell |
822,840
-247,696
| -23% | -$226K | ﹤0.01% | 4012 |
|
|
2024
Q4 | $1.7M | Buy |
1,070,536
+369,644
| +53% | +$588K | ﹤0.01% | 3589 |
|
|
2024
Q3 | $1.37M | Sell |
700,892
-487,872
| -41% | -$956K | ﹤0.01% | 3586 |
|
|
2024
Q2 | $1.95M | Buy |
1,188,764
+585,862
| +97% | +$961K | ﹤0.01% | 3209 |
|
|
2024
Q1 | $3.1M | Sell |
602,902
-57,138
| -9% | -$294K | ﹤0.01% | 2918 |
|
|
2023
Q4 | $3.78M | Buy |
660,040
+264,431
| +67% | +$1.52M | ﹤0.01% | 2784 |
|
|
2023
Q3 | $1.89M | Buy |
395,609
+124,968
| +46% | +$597K | ﹤0.01% | 3130 |
|
|
2023
Q2 | $1.15M | Sell |
270,641
-43,128
| -14% | -$183K | ﹤0.01% | 3532 |
|
|
2023
Q1 | $1.67M | Sell |
313,769
-39,128
| -11% | -$208K | ﹤0.01% | 3336 |
|
|
2022
Q4 | $2.22M | Sell |
352,897
-215,432
| -38% | -$1.35M | ﹤0.01% | 3214 |
|
|
2022
Q3 | $6M | Buy |
568,329
+428,011
| +305% | +$4.52M | ﹤0.01% | 2514 |
|
|
2022
Q2 | $761K | Sell |
140,318
-139,140
| -50% | -$755K | ﹤0.01% | 4124 |
|
|
2022
Q1 | $2.57M | Buy |
279,458
+247,735
| +781% | +$2.27M | ﹤0.01% | 3367 |
|
|
2021
Q4 | $478K | Buy |
+31,723
| New | +$478K | ﹤0.01% | 4553 |
|